Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 67,149 | 76,751 | 84,585 | 81,800 | 60,007 |
| Marketable Securities | 29,683 | 30,412 | 11,354 | 3,229 | 14,432 |
| Receivables | 28,105 | 24,584 | 47,837 | 28,974 | 31,290 |
| Inventories | 9,049 | 7,100 | 7,080 | 5,679 | 7,631 |
| Other current assets | 241 | 255 | 912 | 1,988 | 573 |
| TOTAL | $137,720 | $143,026 | $156,185 | $125,354 | $118,552 |
| Non-Current Assets | |||||
| PPE Net | 680 | 757 | 855 | 907 | 977 |
| Intangibles | 56,001 | 58,436 | 60,871 | 63,305 | 65,740 |
| Other Non-Current Assets | 10,601 | 11,930 | 12,617 | 14,039 | 15,225 |
| TOTAL | $67,282 | $71,123 | $74,343 | $78,251 | $81,942 |
| Total Assets | $205,002 | $214,149 | $230,528 | $203,605 | $200,494 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 45,329 | 45,329 | 33,997 | 22,664 | 11,332 |
| Accounts payable and accrued liabilities | 13,500 | 8,964 | 6,889 | 5,061 | 7,795 |
| Accrued Expenses | 39,005 | 37,716 | 52,721 | 33,773 | 35,496 |
| Other current liabilities | 1,303 | 1,205 | 975 | 1,236 | 1,204 |
| TOTAL | $104,296 | $98,191 | $99,382 | $67,362 | $60,287 |
| Non-Current Liabilities | |||||
| Long Term Debt | 43,735 | 54,691 | 65,659 | 76,634 | 87,622 |
| Other Non-Current Liabilities | 8,462 | 10,285 | 12,045 | 20,867 | 22,186 |
| TOTAL | $52,197 | $64,976 | $77,704 | $97,501 | $109,808 |
| Total Liabilities | $156,493 | $163,167 | $177,086 | $164,863 | $170,095 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 49,047 | 48,239 | 48,207 | 47,571 | 47,510 |
| Common Shares | 5 | 5 | 5 | 5 | 5 |
| Retained earnings | -1,354,508 | -1,349,979 | -1,345,164 | -1,357,432 | -1,363,228 |
| Other shareholders' equity | -32 | -26 | -4 | -4 | -6 |
| TOTAL | $48,509 | $50,982 | $53,442 | $38,742 | $30,399 |
| Total Liabilities And Equity | $205,002 | $214,149 | $230,528 | $203,605 | $200,494 |